A Cost-Effectiveness Analysis of Emicizumab Tre...

By HEOR Staff Writer

April 17, 2024

Introduction: The Future of Haemophilia A Treatment When it comes to rare blood diseases, the introduction of Emicizumab, a bispecific monoclonal antibody, has been a significant milestone in the
Innovative Technology Policy: Simulation Modelling in Healthcare
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
Vaccination Strategies Impact: India’s Maximising Immunisation Benefit
Digital Health: The Impact of Standardising DHI Terminology
The Clinical and Economic Impact of Universal CMV Screening in Newborns
AI in Healthcare Value Creation and Competitive Advantage
Strategic Cost Implications of Medical Countermeasure Stockpiling
Evaluating the Cost-Effectiveness of Adebrelimab in ES-SCLC
Economic Impact of Diabetes and High-Deductible Health Plans
Forecasting Multidimensional Poverty: South Africa’s Policy Design
The Cost of Mental Health Care: A Cost-Sharing Law
Cost of HPV Vaccination: A Global Economic Perspective